scispace - formally typeset
K

Kathleen M. Downey

Researcher at University of Miami

Publications -  58
Citations -  4359

Kathleen M. Downey is an academic researcher from University of Miami. The author has contributed to research in topics: DNA polymerase & DNA polymerase delta. The author has an hindex of 36, co-authored 58 publications receiving 4314 citations. Previous affiliations of Kathleen M. Downey include Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein

TL;DR: It is shown that PCNA and the polyrnerase-δ auxiliary protein have similar electrophoretic behaviour and are both recognized by anti-PCNA human autoantibodies, and both proteins are functionally equivalent; they stimulate SV40 DNA replication in vitro and increase the processivity of calf thymus DNA polymerase- δ.
Journal ArticleDOI

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

TL;DR: Evaluation of a BHAP in HIV-1-infected SCID-hu mice (severe combined immunodeficient mice implanted with human fetal lymph node) showed that the compound could block HIV- 1 replication in vivo.
Journal ArticleDOI

A new mammalian DNA polymerase with 3' to 5' exonuclease activity: DNA polymerase δ

TL;DR: A new species of DNA polymerase has been purified more than 10 000-fold from the cytoplasm of erythroid hyperplastic bone marrow and results are consistent with the coexistence of two enzyme activities in a single protein.
Journal ArticleDOI

Further studies on calf thymus DNA polymerase delta purified to homogeneity by a new procedure.

TL;DR: DNA polymerase delta from calf thymus has been purified to apparent homogeneity by a new procedure which utilizes hydrophobic interaction chromatography with phenyl-Sepharose at an early step to separate most of the calcium-dependent protease activity from DNA polymeraseDelta and alpha.
Journal ArticleDOI

U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.

TL;DR: Although the RT amino acid substitutions K103N (lysine 103 to asparagine) and Y181C (tyrosine 181 to cysteine), which confer cross-resistance to several nonnucleoside inhibitors, also decrease the potency of U-90152, this drug retains significant activity against these mutant RTs in vitro.